•
DSciLab Co., Ltd, a China-based mRNA pharmaceutical company nurtured by Fosun Health Capital, has announced the completion of an angel financing round worth RMB 100 million. The round was led by Fosun Health Capital, with participation from Shanghai Creation Investment. The funds will be directed towards the advancement of core…